Rose Jalang’o

Biographic Data

ID7581247
NAMERose Jalang’o
GIVEN NAMESRose
FAMILY NAMEJalang’o
SIGNATUREJALANG’O R
AFFILIATIONSMinistry of Health
ORCID0000-0003-3457-2587
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Cost-effectiveness and budget impact analyses of strategies to improve measles vaccination coverage in Kenya

    Open AccessStacey Orangi, Prashant Mandaliya et al.ARTICLEPLOS Global Public Health2026

    Measles control efforts have been implemented over the years. However, elimination of the disease is yet to be realized. Additionally, global measles vaccination coverage has stagnated over the past decade, leading to outbreaks. We assessed the cost-effectiveness and budget impact of scaling-up vaccination coverage in Kenya, towards the measles elimination goal. A cost-effectiveness analysis was conducted using a Markov model from a health system…

  • Contextualizing future maternal RSV vaccination acceptance and trust among pregnant and lactating women in Kenya

    Open AccessMolly Sauer, Berhaun Fesshaye et al.ARTICLEPLOS Global Public Health2025

    Maternal vaccination, or vaccination in pregnancy, offers a critical opportunity to provide protection to pregnant women and simultaneously confer passive immunity to infants in the first months of life, when infections are particularly serious and their immune systems are still developing. Respiratory syncytial virus (RSV) is one such serious infectious disease for newborns, but a newly approved and recommended vaccine for respiratory syncytial …

  • Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya

    Open AccessJessica L Schue, Berhaun Fesshaye et al.ARTICLEPLOS Global Public Health2025

    New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women …

  • Active vaccine safety surveillance

    Open AccessDon B Odhiambo, Donald Akech et al.ARTICLEPLOS Global Public Health2025

    Although active vaccine safety surveillance (VSS) can complement passive VSS while overcoming the inherent limitations of spontaneous safety monitoring, it remains rare in sub-Saharan Africa. We conducted post-authorization active VSS of COVID-19 vaccines in Kilifi, Kenya using a cohort event monitoring study design. Participants were followed weekly over 13 weeks for adverse events. A subset was followed daily for one week for solicited systemic…

  • Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines

    Open AccessRupali J Limaye, Berhaun Fesshaye et al.ARTICLEHealth Policy and Planning2025

    New vaccine policy adoption is a complex process, especially in low-and-middle-income countries, requiring country policymakers to navigate challenges such as competing priorities, human and financial resource constraints, and limited logistical capacity. Since the beginning of the Expanded Programme on Immunization, most new vaccine introductions under this structure have not been aimed at adult populations. The majority of adult vaccines offere…

  • Urgent support mechanism

    Open AccessMosoka Papa Fallah, Senga Sembuche et al.ARTICLEBMJ Global Health2024

    Delivering COVID-19 vaccines with 4–6 weeks shelf life remains one of Africa’s most pressing challenges. The Africa Centres for Disease Control and Prevention (Africa CDC) leadership recognised that COVID-19 vaccines donated to many African countries were at risk of expiry considering the short shelf life on delivery in the Member States and slow vaccine uptake rates. Thus, a streamlined rapid response system, the urgent support mechanism, was de…

  • Spatial access inequities and childhood immunisation uptake in Kenya

    Open AccessNoel K Joseph, Peter M Macharia et al.ARTICLEBMC Public Health2020

    Travel time to immunising health facilities is a barrier to uptake of childhood vaccines in regions with suboptimal accessibility (> 2-h). Strategies that address access barriers in the hardest to reach communities are needed to enhance equitable access to immunisation services in Kenya

  • Determinants of contraceptive use among postpartum women in a county hospital in rural Kenya

    Open AccessRose Jalang’o, Faith Thuita et al.ARTICLEBMC Public Health2017

    Contraceptive uptake was high among postpartum women, who desired to procure contraceptives at health facilities. However, there was unmet need for contraceptives among women who desired no more children. Government health facility stock outs represent a missed opportunity to get family planning methods, especially long acting reversible contraceptives, to postpartum women